Clinical Trial Update: Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating nivolumab in combination with BMS-986205 and radiation therapy, with or without temozolomide, for newly diagnosed glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• BMS-986205 (BMS-986205)
• Temozolomide (Temozolomide)
• nivolumab (nivolumab)

Snippet

Sponsor: Northwestern University | Conditions: Glioblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING